CARA Insider Trading

Insider Ownership Percentage: 3.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $5,232.84

Cara Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cara Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cara Therapeutics Share Price & Price History

Current Price: $5.20
Price Change: Price Decrease of -0.4 (-7.14%)
As of 02/14/2025 05:00 PM ET

This chart shows the closing price history over time for CARA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cara Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2024Christopher PosnerCEOSell328$9.00$2,952.0014,715View SEC Filing Icon  
4/5/2024Joana GoncalvesInsiderSell229$9.96$2,280.844,447View SEC Filing Icon  
2/8/2024Christopher PosnerCEOSell2,964$6.36$18,851.0415,529View SEC Filing Icon  
2/8/2024Ryan D MaynardCFOSell457$6.36$2,906.52667View SEC Filing Icon  
2/8/2024Scott TerrillionInsiderSell647$6.36$4,114.927,857View SEC Filing Icon  
2/1/2024Christopher PosnerCEOSell415$6.60$2,739.0018,494View SEC Filing Icon  
11/2/2023Christopher PosnerCEOSell316$14.64$4,626.2413,700View SEC Filing Icon  
8/3/2023Christopher PosnerCEOSell358$36.84$13,188.7214,017View SEC Filing Icon  
6/23/2023Frederique Ph.D. MenzaghiSVPSell249$42.12$10,487.8812,812View SEC Filing Icon  
6/23/2023Scott TerrillionInsiderSell206$42.12$8,676.727,380View SEC Filing Icon  
5/5/2023Christopher PosnerCEOSell322$52.80$17,001.6014,376View SEC Filing Icon  
4/4/2023Frederique Ph.D. MenzaghiSVPSell227$58.92$13,374.8413,061View SEC Filing Icon  
4/4/2023Scott TerrillionInsiderSell206$58.92$12,137.527,587View SEC Filing Icon  
2/2/2023Christopher PosnerCEOSell349$141.60$49,418.4015,197View SEC Filing Icon  
1/17/2023Joana GoncalvesInsiderSell188$129.72$24,387.365,614View SEC Filing Icon  
12/21/2022Frederique Ph.D. MenzaghiSVPSell292$135.24$39,490.0813,856View SEC Filing Icon  
12/21/2022Joana GoncalvesInsiderSell249$135.24$33,674.765,991View SEC Filing Icon  
11/16/2022Christopher PosnerCEOSell1,205$133.56$160,939.8015,546View SEC Filing Icon  
9/14/2022Martin VogelbaumDirectorSell900$123.36$111,024.003,749View SEC Filing Icon  
7/15/2022Jeffrey L. IvesDirectorSell300$108.60$32,580.001,289View SEC Filing Icon  
4/4/2022Christopher PosnerCEOSell167$152.04$25,390.6816,752View SEC Filing Icon  
4/1/2022Frederique Ph.D. MenzaghiSVPSell148$142.92$21,152.1614,148View SEC Filing Icon  
4/1/2022Scott TerrillionInsiderSell136$142.92$19,437.126,241View SEC Filing Icon  
3/3/2022Scott TerrillionInsiderSell148$136.56$20,210.88View SEC Filing Icon  
3/3/2022Thomas Charles ReillyCFOSell170$136.56$23,215.20View SEC Filing Icon  
2/25/2022Scott TerrillionInsiderSell164$123.48$20,250.72View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cara Therapeutics (NASDAQ:CARA)

44.66% of Cara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CARA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cara Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Two Sigma Advisers LP64,180$0.39M0.0%-92.6%1.404%Search for SEC Filing on Google Icon
2/17/2025Shay Capital LLC85,692$0.52M0.1%N/A1.875%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC39,441$0.24M0.0%-93.3%0.863%Search for SEC Filing on Google Icon
2/17/2025Farallon Capital Management LLC129,685$0.79M0.0%-91.7%2.838%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets13,372$82K0.0%-97.7%0.293%Search for SEC Filing on Google Icon
2/14/2025Curi RMB Capital LLC45,333$0.28M0.0%N/A0.992%Search for SEC Filing on Google Icon
2/13/2025Rockefeller Capital Management L.P.155,717$0.95M0.0%N/A3.407%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC94,030$0.58M0.0%-91.5%2.058%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC37,684$0.23M0.0%-91.7%0.825%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC12,218$75K0.0%-91.8%0.267%Search for SEC Filing on Google Icon
11/15/2024Disciplined Growth Investors Inc. MN1,113,043$0.34M0.0%-42.5%2.029%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd94,709$29K0.0%N/A0.173%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp332,995$0.10M0.0%-24.9%0.607%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets582,536$0.18M0.0%-45.9%1.062%Search for SEC Filing on Google Icon
11/13/2024FMR LLC210,312$65K0.0%+18.5%0.383%Search for SEC Filing on Google Icon
8/16/2024Disciplined Growth Investors Inc. MN1,935,718$0.50M0.0%+6.6%3.540%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC1,065,750$0.28M0.0%-20.0%1.949%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC267,303$68K0.0%-20.0%0.489%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC334,231$0.30M0.0%-7.3%0.611%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,481,258$2.26M0.0%-5.7%4.539%Search for SEC Filing on Google Icon
5/7/2024Marquette Asset Management LLC94,238$86K0.0%N/A0.172%Search for SEC Filing on Google Icon
4/25/2024Rosalind Advisors Inc.1,548,893$1.41M1.3%N/A2.833%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.831,849$0.62M0.0%+3.5%1.527%Search for SEC Filing on Google Icon
1/30/2024Mackenzie Financial Corp53,678$40K0.0%+71.2%0.099%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.167,838$0.13M0.0%+155.8%0.308%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.44,821$75K0.0%-24.0%0.082%Search for SEC Filing on Google Icon
12/1/2023B. Riley Wealth Advisors Inc.55,648$93K0.0%-64.1%0.102%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC58,750$99K0.0%N/A0.109%Search for SEC Filing on Google Icon
11/13/2023Clearbridge Investments LLC971,610$1.63M0.0%-2.7%1.797%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC228,675$0.38M0.0%N/A0.423%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.65,608$0.11M0.0%N/A0.121%Search for SEC Filing on Google Icon
10/25/2023Mackenzie Financial Corp31,349$51K0.0%N/A0.058%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp165,252$0.28M0.0%-12.6%0.306%Search for SEC Filing on Google Icon
10/24/2023Pinnacle Associates Ltd.649,253$1.09M0.0%-3.4%1.201%Search for SEC Filing on Google Icon
10/18/2023IQ EQ FUND MANAGEMENT IRELAND Ltd848,845$1.43M0.3%+904.2%1.570%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC67,954$0.11M0.0%+36.1%0.126%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC9,346$26K0.0%-67.1%0.017%Search for SEC Filing on Google Icon
9/7/2023Jag Capital Management LLC11,235$32K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/15/2023Bain Capital Life Sciences Investors LLC934,898$2.65M0.3%-57.6%1.729%Search for SEC Filing on Google Icon
8/14/2023Shay Capital LLC12,500$35K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.19,168$54K0.0%N/A0.035%Search for SEC Filing on Google Icon
8/11/2023Jag Capital Management LLC11,235$32K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/11/2023Clearbridge Investments LLC998,074$2.83M0.0%+105.6%1.846%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.17,900$51K0.0%-93.6%0.033%Search for SEC Filing on Google Icon
8/7/2023Mirabella Financial Services LLP14,257$40K0.0%N/A0.026%Search for SEC Filing on Google Icon
7/27/2023B. Riley Wealth Advisors Inc.154,990$0.44M0.0%+218.6%0.287%Search for SEC Filing on Google Icon
7/27/2023Pinnacle Associates Ltd.672,440$1.90M0.0%-1.0%1.246%Search for SEC Filing on Google Icon
7/24/2023Allspring Global Investments Holdings LLC22,158$63K0.0%+2,846.5%0.041%Search for SEC Filing on Google Icon
7/18/2023Allspring Global Investments Holdings LLC22,158$63K0.0%+2,846.5%0.041%Search for SEC Filing on Google Icon
7/18/2023Rothschild Investment Corp IL15,100$43K0.0%-46.8%0.028%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC49,932$0.14M0.0%-33.5%0.093%Search for SEC Filing on Google Icon
5/16/2023Bain Capital Life Sciences Investors LLC2,204,449$10.82M1.4%-18.2%4.084%Search for SEC Filing on Google Icon
5/15/2023Kingdon Capital Management L.L.C.1,233,000$6.05M1.1%-7.5%2.284%Search for SEC Filing on Google Icon
5/15/2023Farallon Capital Management LLC1,995,370$9.80M0.1%-3.8%3.697%Search for SEC Filing on Google Icon
5/12/2023Clearbridge Investments LLC485,535$2.38M0.0%+18.8%0.900%Search for SEC Filing on Google Icon
5/11/2023ExodusPoint Capital Management LP213,644$1.05M0.0%-42.5%0.396%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.184,349$0.91M0.0%N/A0.342%Search for SEC Filing on Google Icon
5/5/2023Pinnacle Associates Ltd.679,413$3.34M0.1%-1.2%1.259%Search for SEC Filing on Google Icon
5/2/2023Yousif Capital Management LLC26,035$0.13M0.0%-9.4%0.048%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC20,582$0.10M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/1/2023Texas Permanent School Fund Corp48,495$0.24M0.0%+89.3%0.090%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC75,067$0.37M0.0%+56.2%0.139%Search for SEC Filing on Google Icon
4/24/2023Rothschild Investment Corp IL28,400$0.14M0.0%-51.9%0.053%Search for SEC Filing on Google Icon
4/24/2023Penserra Capital Management LLC160,290$0.79M0.0%-9.2%0.297%Search for SEC Filing on Google Icon
3/15/2023B. Riley Wealth Advisors Inc.46,148$0.50M0.0%+4.5%0.086%Search for SEC Filing on Google Icon
2/14/2023Penserra Capital Management LLC176,486$1.90M0.0%+1.6%0.328%Search for SEC Filing on Google Icon
2/13/2023ExodusPoint Capital Management LP371,262$3.99M0.1%+184.4%0.691%Search for SEC Filing on Google Icon
2/13/2023Martingale Asset Management L P39,039$0.42M0.0%+233.7%0.073%Search for SEC Filing on Google Icon
2/10/2023New York Life Investment Management LLC46,688$0.50M0.0%+12.7%0.087%Search for SEC Filing on Google Icon
2/10/2023Clearbridge Investments LLC408,738$4.39M0.0%-6.4%0.761%Search for SEC Filing on Google Icon
2/9/2023Mirae Asset Global Investments Co. Ltd.22,574$0.24M0.0%+14.0%0.042%Search for SEC Filing on Google Icon
2/9/2023Victory Capital Management Inc.161,020$1.73M0.0%+33.5%0.300%Search for SEC Filing on Google Icon
2/9/2023Principal Financial Group Inc.284,658$3.06M0.0%-3.3%0.530%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.74,090$0.80M0.0%+1.3%0.138%Search for SEC Filing on Google Icon
2/8/2023IQ EQ FUND MANAGEMENT IRELAND Ltd76,325$0.82M0.2%+5.2%0.142%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank110,200$1.18M0.0%+2.0%0.205%Search for SEC Filing on Google Icon
2/7/2023Texas Permanent School Fund25,615$0.28M0.0%-20.5%0.048%Search for SEC Filing on Google Icon
2/7/2023Fox Run Management L.L.C.13,811$0.15M0.1%N/A0.026%Search for SEC Filing on Google Icon
2/7/2023LPL Financial LLC175,852$1.89M0.0%-1.2%0.327%Search for SEC Filing on Google Icon
2/6/2023Los Angeles Capital Management LLC54,170$0.58M0.0%-43.2%0.101%Search for SEC Filing on Google Icon
2/2/2023SG Americas Securities LLC48,067$0.52M0.0%+3.7%0.089%Search for SEC Filing on Google Icon
2/2/2023Cypress Capital Management LLC WY5,350$57K0.1%-28.1%0.010%Search for SEC Filing on Google Icon
2/2/2023Intrepid Financial Planning Group LLC11,500$0.12M0.1%-20.7%0.021%Search for SEC Filing on Google Icon
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank7,610$82K0.0%+29.3%0.014%Search for SEC Filing on Google Icon
2/1/2023Pinnacle Associates Ltd.687,885$7.39M0.2%-2.5%1.280%Search for SEC Filing on Google Icon
1/31/2023Everence Capital Management Inc.11,140$0.12M0.0%N/A0.021%Search for SEC Filing on Google Icon
1/30/2023New York State Common Retirement Fund30,979$0.33M0.0%+19.2%0.058%Search for SEC Filing on Google Icon
1/26/2023Comerica Bank26,629$0.29M0.0%-21.5%0.050%Search for SEC Filing on Google Icon
1/25/2023Pinnacle Associates Ltd.710,692$7.95M0.2%+0.8%1.323%Search for SEC Filing on Google Icon
1/19/2023Rothschild Investment Corp IL59,000$0.63M0.1%+1.9%0.110%Search for SEC Filing on Google Icon
1/12/2023Assenagon Asset Management S.A.101,544$1.09M0.0%+210.5%0.189%Search for SEC Filing on Google Icon
1/9/2023Yousif Capital Management LLC28,735$0.31M0.0%-33.4%0.053%Search for SEC Filing on Google Icon
11/15/2022Disciplined Growth Investors Inc. MN1,700,230$15.91M0.4%+0.1%3.164%Search for SEC Filing on Google Icon
11/15/2022Martingale Asset Management L P11,700$0.11M0.0%-53.8%0.022%Search for SEC Filing on Google Icon
11/15/2022Brandywine Global Investment Management LLC43,336$0.41M0.0%-3.7%0.081%Search for SEC Filing on Google Icon
11/14/2022Tudor Investment Corp Et Al133,603$1.25M0.0%+40.4%0.249%Search for SEC Filing on Google Icon
11/14/2022PDT Partners LLC25,257$0.24M0.0%-37.8%0.047%Search for SEC Filing on Google Icon
11/14/2022Penserra Capital Management LLC173,686$1.63M0.0%-12.6%0.323%Search for SEC Filing on Google Icon
11/14/2022MML Investors Services LLC43,147$0.40M0.0%+170.6%0.080%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP193,000$1.81M0.7%-45.4%0.359%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cara Therapeutics logo
Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.
Read More on Cara Therapeutics

Today's Range

Now: $5.20
Low: $5.17
High: $5.59

50 Day Range

MA: $4.79
Low: $3.00
High: $6.12

52 Week Range

Now: $5.20
Low: $2.71
High: $13.80

Volume

22,838 shs

Average Volume

47,295 shs

Market Capitalization

$23.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.5

Who are the company insiders with the largest holdings of Cara Therapeutics?

Cara Therapeutics' top insider investors include:
  1. Christopher Posner (CEO)
  2. Frederique PhD Menzaghi (SVP)
  3. Scott Terrillion (Insider)
  4. Joana Goncalves (Insider)
  5. Ryan D Maynard (CFO)
Learn More about top insider investors at Cara Therapeutics.

Who are the major institutional investors of Cara Therapeutics?

Cara Therapeutics' top institutional investors include:
  1. Rockefeller Capital Management L.P. — 3.41%
  2. Farallon Capital Management LLC — 2.84%
  3. Renaissance Technologies LLC — 2.06%
  4. Shay Capital LLC — 1.88%
  5. Two Sigma Advisers LP — 1.40%
  6. Curi RMB Capital LLC — 0.99%
Learn More about top institutional investors of Cara Therapeutics stock.

Which institutional investors are selling Cara Therapeutics stock?

During the last quarter, CARA stock was sold by these institutional investors:
  1. Farallon Capital Management LLC
  2. Renaissance Technologies LLC
  3. Two Sigma Advisers LP
  4. BNP Paribas Financial Markets
  5. Millennium Management LLC
  6. Geode Capital Management LLC
  7. LPL Financial LLC
During the previous year, company insiders that have sold Cara Therapeutics company stock include:
  1. Christopher Posner (CEO)
  2. Frederique PhD Menzaghi (SVP)
Learn More investors selling Cara Therapeutics stock.

Which institutional investors are buying Cara Therapeutics stock?

During the previous quarter, CARA stock was purchased by institutional investors including:
  1. Rockefeller Capital Management L.P.
  2. Shay Capital LLC
  3. Curi RMB Capital LLC